All
(Some) business is booming: ASDS figures show cosmetic procedures still robust
September 1st 2008Despite concerns about the U.S. economy, a March 2008 survey by the American Society for Dermatologic Surgery (ASDS) showed that nearly one-fourth of the survey's 562 respondents were experiencing increased bookings for existing aesthetic patients versus fall 2007.
Ups & downs: As economy ebbs, top-notch service, noninvasive procedures keep derms afloat
September 1st 2008While dermatologists offer mixed assessments of the impact of the sluggish U.S. economy on their specialty, they say today's tighter market clearly is intensifying the trend toward noninvasive procedures.
Skin Cancer Foundation accepts grant applications
August 29th 2008New York - The Skin Cancer Foundation is now accepting applications for its annual awards to support pilot research projects related to skin cancer. The foundation will award four $10,000 grants for basic research and clinical studies that address improved methods of prevention, detection and treatment of skin cancer.
Danish study reveals efficacy of combination therapy in treating scalp psoriasis
August 26th 2008Copenhagen, Denmark - Danish researchers have found that combination therapy using betamethasone dipropionate and calcipotriene is more effective for treating scalp psoriasis than either component alone, HealthDay News reports.
Teaming up: Vascular anomaly centers focus on multidisciplinary approach
August 20th 2008Chicago - The concept of too many cooks in the kitchen does not apply to treating vascular anomalies. In fact, experts say, even dermatologists often need to tap into the expertise of multidisciplinary centers that focus on vascular anomalies and other "orphan" skin diseases in order to offer optimum care - especially for their pediatric patients.
Cipher announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
August 8th 2008Mississauga, Ontario - Cipher Pharmaceuticals announces it has entered into a distribution and supply agreement with Ranbaxy Laboratories Limited for Ranbaxy to market, sell and distribute CIP-ISOTRETINOIN in the United States, MarketWatch reports.
California legislators defeat bill requiring proof of minimum lead levels in lipsticks
August 5th 2008Sacramento, Calif. - The California Assembly’s Committee on Health has defeated a bill that would have required manufacturers - including lipstick-makers - to prove that their products contain no more than “an unavoidable trace of lead,” CosmeticsDesign.com reports.
Study makes case for renewed interest in carbon dioxide laser resurfacing
August 5th 2008Ann Arbor, Mich. - New research suggests that a form of laser cosmetic surgery first used two decades ago - but which has since fallen out of favor - could make a comeback in treating facial wrinkles, London’s Daily Mail reports.
Opponents square off in online debate over whether sun exposure causes melanoma
August 5th 2008London - The issue of whether sun exposure is a major cause of melanoma is the subject of two opposing articles published July 22 on bmj.com, the Web site of the British Medical Journal, HealthDay News reports.
PhRMA survey offers insights on doctors’ prescription-drug decision-making process
August 5th 2008Washington - More than 90 percent of physicians base their drug-prescribing decisions on multiple sources of information, according to a new survey conducted by the Pharmaceutical Research and Manufacturers of America (PhRMA), PRNewswire reports.
Column: Feeling the crunch: Unstable market affects home buyers, remodelers
August 1st 2008The subprime mortgage crunch is rippling through our economy in a variety of different ways. Many homeowners are postponing plans to sell until the market stabilizes; others, with hopes for trading up to a bigger home, are opting to stay put, turning instead to remodeling or enlarging.
Column: Weighing the options: Protecting your assets during a medical malpractice crisis
August 1st 2008You don't need to read another article telling you how terrible the malpractice crisis is. You already know that lawsuits are on the rise, jury awards are out of control, malpractice premiums are escalating to the point of being unaffordable, and the practice of medicine as we know it is severely threatened.